Isosceles Pharmaceuticals
Timothy R. Wright serves as the Chairman of the Board of Directors at Isosceles Pharmaceuticals and is the Founder and Partner at Signal Hill Advisors. Wright has held significant leadership positions, including Chief Executive Officer at MiMedx and President and Chief Executive Officer at M2GEN. Additionally, Wright served as Executive Vice President of Corporate Strategy, Global Business Development, and Innovation at Teva Pharmaceuticals. Wright holds a degree from The Ohio State University.
This person is not in the org chart
This person is not in any teams
Isosceles Pharmaceuticals
Isosceles Pharmaceuticals is an preclinical stage biotech developing a perioperative acute pain product candidates using actives with an approved drug master file and an excellent safety profile.